Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.
about
Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriersFamilial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigreePostprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins.Lipoprotein binding and endosomal itinerary of the low density lipoprotein receptor-related protein in rat liver.Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia)Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozilRole of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemiaLinks between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor.Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.Regulation of low density lipoprotein receptors by plasma lipoproteins from patients with abetalipoproteinemia.ApoE genotype: from geographic distribution to function and responsiveness to dietary factors.Regulation of sterol transport in human microvascular endothelial cellsEffect of apolipoproteins E and C-III on the interaction of chylomicrons with parenchymal and non-parenchymal cells from rat liver.The effect of tibolone on the lipoprotein profile of postmenopausal women with type III hyperlipoproteinemia.ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels.
P2860
Q33821952-FDE80579-B7CF-4DC0-AAEC-D05C945F296BQ33822165-F0669D63-A129-487E-BC58-EBE3BEA447EFQ34137756-3CD45392-B906-4D0D-BC6E-869B5A442E6FQ34185850-5E1FBAF6-DD30-44C7-8CC7-00BD8B44EB76Q34194380-32B51B40-D47A-4009-8166-18448881A192Q34245790-30A1D018-B854-4633-8A2F-FEBF68396331Q34322965-C84A5358-B3DD-4748-BA07-8BA0723391B8Q34538275-0BF09452-0A65-4656-BA10-03B73B717182Q34560246-4E39902C-326F-42DA-B971-0CC8B3567357Q34567075-53C716F0-CD5C-425D-B409-CF4BF5C738C6Q35200206-B9A28CBF-15C2-462E-9609-DBEC017ED12DQ35205937-CF9EE4CC-163C-4B65-84CC-AE5BB15FB086Q35676929-89F83C8B-23A4-4711-818D-A45B70820B7CQ36299005-56D739F4-0CE8-4F74-BA8E-6A72B0AA73B5Q36306690-D0CE4869-3B34-4090-9ED6-55AA7F61BEACQ36383153-A3DEF209-DEC0-4C90-A3FE-88132FA832CDQ37004383-9B73E986-A1A5-4414-84F9-E6A23C952CD5Q37016558-A33FAA45-A986-4BFE-8981-45A0C40D8483Q37026784-9917A8F0-0BFB-402E-BC34-D204ECDF1856Q37352384-595D9B6B-788F-4D95-92F4-A6463267D837Q37380855-AB5673B6-B2BC-44C6-8095-44FC0B85DD7EQ37614130-97A25A99-1477-4824-90AC-9BB14CFF1643Q38008109-53E16470-0C00-474B-BC25-BFE1BFB2A710Q41442539-969A0C01-D26C-40F3-B091-7B976ADB2336Q42865714-478166FD-082C-485C-8DE4-FB4F8B0774A1Q43927139-7EBDCB51-7E04-410D-B367-753E663DCECCQ44871480-5F0BC08F-AD38-4CF5-890E-267357B26E3B
P2860
Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Isoprotein specificity in the ...... milial dysbetalipoproteinemia.
@ast
Isoprotein specificity in the ...... milial dysbetalipoproteinemia.
@en
type
label
Isoprotein specificity in the ...... milial dysbetalipoproteinemia.
@ast
Isoprotein specificity in the ...... milial dysbetalipoproteinemia.
@en
prefLabel
Isoprotein specificity in the ...... milial dysbetalipoproteinemia.
@ast
Isoprotein specificity in the ...... milial dysbetalipoproteinemia.
@en
P2093
P2860
P356
P1476
Isoprotein specificity in the ...... milial dysbetalipoproteinemia.
@en
P2093
P2860
P304
P356
10.1073/PNAS.77.7.4349
P407
P577
1980-07-01T00:00:00Z